-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Local European time, on April 14, Denmark announced that it would stop using AstraZeneca-Oxford University's new crown vaccine, becoming the first country to completely stop using the vaccine, but it does not rule out the use of the vaccine in the future .
Denmark’s vaccination work has been postponed from late July to August.
Denmark’s vaccination work has been postponed from late July to August.
The Danish Health Agency said in a statement on Wednesday that “the use of AstraZeneca’s COVID-19 vaccine poses a serious risk of side effects.
"The use of AstraZeneca's COVID-19 vaccine poses a serious risk of side effects.
The statement pointed out that since March 11, EMA (European Medicines Agency) has completed the review of very rare but serious side effects in people receiving the new crown vaccine from AstraZeneca.
management
However, Czech Interior Minister Jan Hamacek tweeted on Wednesday that the Czech Republic will buy excess AstraZeneca vaccines from Denmark.
Leave a message here